Terveystalo has issued a profit warning, forecasting that its adjusted operating profit (EBIT) for the current year will fall within the range of EUR 120 million to EUR 140 million.
The guidance represents a downward revision from the company's previous estimates, prompting a sharp reassessment of the stock by investors.
Shares in the Helsinki-listed healthcare provider fell more than 7% in early trading following the announcement.
Shares in the Helsinki-listed healthcare provider fell more than 7% in early trading following the announcement.
The sell-off reflects market concern over the durability of the company's margins and the potential impact of the revised outlook on full-year earnings per share.
The development adds to a recent wave of corporate profit warnings across European markets.
In similar moves, UK housebuilder Vistry Group saw shares drop over 8% after warning of a pre-tax loss, while German biotech firm Evotec AG tumbled approximately 30% on a profit warning that sent its stock to a decade low.